<DOC>
	<DOC>NCT00933023</DOC>
	<brief_summary>Topical steroids are used as treatment for non-retractile foreskin in children for decades, but, there are disagreement among physicians about the optimum potency of the agent used. This study is designed to determine any difference in the beneficial effects of mild versus potent topical corticosteroids in treatment of non-retractile foreskin in children.</brief_summary>
	<brief_title>Mild Versus Potent Corticosteroids as Treatment for Phimosis in Children</brief_title>
	<detailed_description />
	<mesh_term>Phimosis</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<criteria>Children 216 with nonretractile foreskin Balanitis xerotica obliterans, balanitis, &lt;2yrs</criteria>
	<gender>Male</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>